HB8084, titled the Access to LARCs Act, would require the Secretary of Health and Human Services to study contraceptive access at community health centers located in “health care deserts” and then report the findings to Congress within 180 days of enactment. The bill focuses on whether women eligible for federal health care benefits can obtain a range of contraceptive methods at these centers, and it directs the study to examine barriers such as reimbursement, inventory stocking, provider training, and patient education.
The bill defines several key terms for the study, including “community health center,” “contraceptive method,” “health care desert,” “range of contraceptive methods,” and “women in need.” It also requires the report to identify which community health centers receive Title X funding. The definition of contraceptive method is broad and includes FDA-approved drugs and devices used for contraception, as well as sexual risk avoidance education and natural family planning or other fertility-based methods.
Impact
HB8084 would not directly change substantive health care coverage or mandate new services, but it would create a federal reporting requirement that could inform future policy on reproductive health access in underserved areas. It would affect the Department of Health and Human Services, community health centers as defined under section 330 of the Public Health Service Act, and centers receiving Title X funding by requiring data collection and analysis about contraceptive availability and barriers in areas with limited access to care.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes, the measure appears to be framed as a fact-finding and oversight bill rather than a controversial regulatory change. Its sponsors are Republicans, and the inclusion of both contraceptive access and fertility-based methods suggests an effort to address reproductive health access in a broad way. With no transcript or vote history available, there is no documented opposition or support beyond the introduction and referral stage.
Contention
The main potential points of contention are likely to be the bill’s broad definition of “contraceptive method,” which includes sexual risk avoidance education and natural family planning alongside FDA-approved contraceptives, and the focus on Title X-funded centers. Supporters may view the study as a neutral way to assess access gaps in health care deserts, while critics could question whether the framing dilutes attention to clinical contraception or whether the study could be used to advance broader policy debates over reproductive health services.
Expressing support for the recognition of September 26, 2025, as "World Contraception Day" and expressing the sense of the House of Representatives regarding global and domestic access to contraception.